Aethlon Medical Inc (AEMD) - Net Assets
Based on the latest financial reports, Aethlon Medical Inc (AEMD) has net assets worth $5.20 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.24 Million) and total liabilities ($1.04 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Aethlon Medical Inc (AEMD) strategic asset index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $5.20 Million |
| % of Total Assets | 83.38% |
| Annual Growth Rate | 30.1% |
| 5-Year Change | -71.24% |
| 10-Year Change | 720.65% |
| Growth Volatility | 272.27 |
Aethlon Medical Inc - Net Assets Trend (1997–2026)
This chart illustrates how Aethlon Medical Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Aethlon Medical Inc market capitalisation.
Annual Net Assets for Aethlon Medical Inc (1997–2026)
The table below shows the annual net assets of Aethlon Medical Inc from 1997 to 2026. Also explore Aethlon Medical Inc (AEMD) net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | $4.89 Million | -4.63% |
| 2025-03-31 | $5.12 Million | -11.15% |
| 2024-03-31 | $5.77 Million | -61.72% |
| 2023-03-31 | $15.06 Million | -11.34% |
| 2022-03-31 | $16.99 Million | +82.83% |
| 2021-03-31 | $9.29 Million | +0.18% |
| 2020-03-31 | $9.28 Million | +303.53% |
| 2019-03-31 | $2.30 Million | -61.89% |
| 2018-03-31 | $6.03 Million | +913.21% |
| 2017-03-31 | $595.41K | -60.37% |
| 2016-03-31 | $1.50 Million | +130.64% |
| 2015-03-31 | $651.38K | +104.42% |
| 2014-03-31 | $-14.73 Million | -61.08% |
| 2013-03-31 | $-9.14 Million | +1.63% |
| 2012-03-31 | $-9.30 Million | -55.56% |
| 2011-03-31 | $-5.98 Million | -35.74% |
| 2010-03-31 | $-4.40 Million | -11.47% |
| 2009-03-31 | $-3.95 Million | -18.87% |
| 2008-03-31 | $-3.32 Million | +53.15% |
| 2007-03-31 | $-7.09 Million | -303.05% |
| 2006-03-31 | $-1.76 Million | +42.63% |
| 2005-03-31 | $-3.07 Million | +16.09% |
| 2004-03-31 | $-3.66 Million | -0.82% |
| 2003-03-31 | $-3.63 Million | -64.98% |
| 2002-03-31 | $-2.20 Million | +10.89% |
| 2001-03-31 | $-2.47 Million | -245.84% |
| 2000-03-31 | $-713.05K | -1.21% |
| 1999-03-31 | $-704.50K | -57409.88% |
| 1998-03-31 | $-1.23K | -151.60% |
| 1997-03-31 | $2.37K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Aethlon Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 17507113800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.57K | 0.03% |
| Other Comprehensive Income | $-32.70K | -0.67% |
| Other Components | $180.02 Million | 3684.27% |
| Total Equity | $4.89 Million | 100.00% |
Aethlon Medical Inc Competitors by Market Cap
The table below lists competitors of Aethlon Medical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
River and Mercantile UK Micro Cap Investment Company Ltd
LSE:RMMC
|
$1.02 Million |
|
Gentlemens Equity S.A.
PA:MLGEQ
|
$1.02 Million |
|
Edri-El
TA:EDRL
|
$1.02 Million |
|
Value & Income Trust
LSE:VIP
|
$1.02 Million |
|
General Shopping e Outlets do Brasil S.A.
SA:GSHP3
|
$1.02 Million |
|
Wynnstay Group Plc
LSE:WYN
|
$1.02 Million |
|
PHAXIAM Therapeutics S.A.
PA:PHXM
|
$1.01 Million |
|
BioNeutra Global Corp
V:BGA
|
$1.01 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aethlon Medical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 5,123,530 to 4,886,272, a change of -237,258 (-4.6%).
- Net loss of 7,151,469 reduced equity.
- New share issuances of 6,901,465 increased equity.
- Other comprehensive income decreased equity by 15,570.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-7.15 Million | -146.36% |
| Share Issuances | $6.90 Million | +141.24% |
| Other Comprehensive Income | $-15.57K | -0.32% |
| Other Changes | $28.32K | +0.58% |
| Total Change | $- | -4.63% |
Book Value vs Market Value Analysis
This analysis compares Aethlon Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.20x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.02x to 0.20x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1997-03-31 | $69.82 | $1.43 | x |
| 1998-03-31 | $-36.03 | $1.43 | x |
| 1999-03-31 | $-17612.40 | $1.43 | x |
| 2000-03-31 | $-10186.46 | $1.43 | x |
| 2001-03-31 | $-33324.20 | $1.43 | x |
| 2002-03-31 | $-21544.47 | $1.43 | x |
| 2003-03-31 | $-24497.28 | $1.43 | x |
| 2004-03-31 | $-16766.87 | $1.43 | x |
| 2005-03-31 | $-8200.46 | $1.43 | x |
| 2006-03-31 | $-3377.13 | $1.43 | x |
| 2007-03-31 | $-9876.98 | $1.43 | x |
| 2008-03-31 | $-3622.97 | $1.43 | x |
| 2009-03-31 | $-3449.17 | $1.43 | x |
| 2010-03-31 | $-2915.39 | $1.43 | x |
| 2011-03-31 | $-3219.66 | $1.43 | x |
| 2012-03-31 | $-4567.87 | $1.43 | x |
| 2013-03-31 | $-459.61 | $1.43 | x |
| 2014-03-31 | $-577.72 | $1.43 | x |
| 2015-03-31 | $17.47 | $1.43 | x |
| 2016-03-31 | $30.48 | $1.43 | x |
| 2017-03-31 | $11.50 | $1.43 | x |
| 2018-03-31 | $73.47 | $1.43 | x |
| 2019-03-31 | $200.70 | $1.43 | x |
| 2020-03-31 | $275.55 | $1.43 | x |
| 2021-03-31 | $623.96 | $1.43 | x |
| 2022-03-31 | $928.83 | $1.43 | x |
| 2023-03-31 | $586.80 | $1.43 | x |
| 2024-03-31 | $183.58 | $1.43 | x |
| 2025-03-31 | $32.83 | $1.43 | x |
| 2026-03-31 | $7.25 | $1.43 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aethlon Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -146.36%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.30x
- Recent ROE (-146.36%) is below the historical average (-130.50%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1997 | -64.62% | 0.00% | 0.00x | 1.15x | $-1.77K |
| 1998 | 0.00% | -17.96% | 26.57x | 0.00x | $-3.48K |
| 1999 | 0.00% | 0.00% | 0.00x | 0.00x | $-282.23K |
| 2000 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.23 Million |
| 2001 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.18 Million |
| 2002 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.78 Million |
| 2003 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.10 Million |
| 2004 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.15 Million |
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.79 Million |
| 2006 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.74 Million |
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-5.32 Million |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.81 Million |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-5.69 Million |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.13 Million |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-5.11 Million |
| 2012 | 0.00% | -596.40% | 1.62x | 0.00x | $-7.18 Million |
| 2013 | 0.00% | -397.72% | 2.48x | 0.00x | $-3.98 Million |
| 2014 | 0.00% | -822.48% | 0.96x | 0.00x | $-11.86 Million |
| 2015 | -1043.47% | -891.51% | 0.55x | 2.12x | $-6.86 Million |
| 2016 | -324.29% | -549.53% | 0.35x | 1.70x | $-5.02 Million |
| 2017 | -1222.01% | -1855.78% | 0.23x | 2.90x | $-7.34 Million |
| 2018 | -94.15% | -3796.16% | 0.02x | 1.22x | $-6.28 Million |
| 2019 | -255.45% | -2697.88% | 0.06x | 1.70x | $-6.44 Million |
| 2020 | -67.74% | -980.33% | 0.06x | 1.10x | $-7.31 Million |
| 2021 | -83.22% | -1190.76% | 0.06x | 1.13x | $-8.79 Million |
| 2022 | -60.80% | -3540.90% | 0.02x | 1.13x | $-12.13 Million |
| 2023 | -79.86% | -2094.89% | 0.03x | 1.16x | $-13.54 Million |
| 2024 | -211.71% | 0.00% | 0.00x | 1.43x | $-12.78 Million |
| 2025 | -261.31% | 0.00% | 0.00x | 1.44x | $-13.90 Million |
| 2026 | -146.36% | 0.00% | 0.00x | 1.30x | $-7.64 Million |
Industry Comparison
This section compares Aethlon Medical Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $561,953,781
- Average return on equity (ROE) among peers: -16.96%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aethlon Medical Inc (AEMD) | $5.20 Million | -64.62% | 0.20x | $1.02 Million |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $177.99 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-132.02 Million | 0.00% | 0.00x | $11.08 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $903.35K |
| Adapthealth Corp (AHCO) | $245.55 Million | 0.85% | 0.03x | $800.36 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $6.89 Million | 30.07% | 0.49x | $4.97 Million |
| Allurion Technologies, Inc. (ALUR) | $-34.28 Million | 0.00% | 0.00x | $1.16 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $8.10 Million | -140.88% | 0.21x | $4.00 Million |
| Artivion Inc (AORT) | $7.30 Million | 9.59% | 0.70x | $1.16 Billion |
| Apyx Medical Inc (APYX) | $9.29 Million | -10.75% | 0.15x | $126.79 Million |
About Aethlon Medical Inc
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.